ARCHETYPE Tumour - TNM Cancer staging (openEHR-EHR-CLUSTER.tnm_staging.v1)

Type: openEHR ARCHETYPE
Purpose: A framework archetype for the recording of classification and grading of malignancies using the TNM classification. TNM is the Each malignancy has a unique TNM staging classification and it would be normal to further constrain this archetype to reflect these individual requirements.
Use: May be specialised or template-constrained for each particular tumour. e.g. TNM classification for bronchial carcinoma
Misuse: Should not normally be used for TNM classification without specialisation or template-constraints

Available formats: ADL XML

ARCHETYPE IDopenEHR-EHR-CLUSTER.tnm_staging.v1
ConceptTumour - TNM Cancer staging
DescriptionA framework for the classification and grading of malignancies using the TNM classification system.
UseMay be specialised or template-constrained for each particular tumour. e.g. TNM classification for bronchial carcinoma
MisuseShould not normally be used for TNM classification without specialisation or template-constraints
PurposeA framework archetype for the recording of classification and grading of malignancies using the TNM classification. TNM is the Each malignancy has a unique TNM staging classification and it would be normal to further constrain this archetype to reflect these individual requirements.
ReferencesAmerican Joint Committee on Cancer. TNM schema files [Internet]. [cited 2009 Jul 27 ]
Available from: http://www.cancerstaging.org/education/tnmschema/tnmschema.html

Greene FL, Page DL, Fleming ID. et al, eds, for the American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.

Copyrightcopyright (c) 2009 openEHR Foundation
AuthorsAuthor name: Dr Ian McNicoll
Organisation: Ocean Informatics Scotland
Email: ian.mcnicoll@oceaninformatics.com
Date originally authored: 27/07/2009
Other Details LanguageAuthor name: Dr Ian McNicoll
Organisation: Ocean Informatics Scotland
Email: ian.mcnicoll@oceaninformatics.com
Date originally authored: 27/07/2009
Other Details (Language Independent)
  • References: American Joint Committee on Cancer. TNM schema files [Internet]. [cited 2009 Jul 27 ] Available from: http://www.cancerstaging.org/education/tnmschema/tnmschema.html Greene FL, Page DL, Fleming ID. et al, eds, for the American Joint Committee on Cancer. AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
  • MD5-CAM-1.0.1: 8CBC0E9AFBB0603DA802A38BEC1D0FA6
Keywordstumour, TNM, malignancy, cancer, staging, classification, grade, grading, stage, lymph node, metastasis
LifecycleAuthorDraft
Language useden
Citeable Identifier1013.1.410
items
Clinical (cTNM)Clinical (cTNM): Clinical TNM pre-treatment classification based on physical examination, imaging and biopsies.
Primary tumour (T)Primary tumour (T): Clincal assessment of the primary tumour.
Regional lymph nodes (N)Regional lymph nodes (N): Clinical assessment of the regional lymph nodes.
Distant metastasis (M)Distant metastasis (M): Clinical assessment of distant metastasis.
Residual tumour (R)Residual tumour (R): Clinical assessment of post-treatment residual tumour.
  • RX [Presence of residual tumour cannot be assessed.]
  • RO [No residual tumour.]
  • R1 [Microscopic residual tumour.]
  • R2 [Macroscopic residual tumour.]
Clinical stagingClinical staging: The overall Clinical staging derived from each T, N and M component e.g T1aM0NX. May include additional TNM descriptors.
Clinical stage groupingClinical stage grouping: The TNM Clinical stage grouping.
CommentComment: A text comment on the Clinical staging.
Pathological (pTNM)Pathological (pTNM): Pathological staging. Based on the clinical staging, results of procedures and pathological/histo-pathological assessment.
Primary tumour (pT)Primary tumour (pT): Pathological assessment of the primary tumour.
Regional lymph node (pN)Regional lymph node (pN): Pathological assessment of the regional lymph nodes.
Distant metastasis (pM)Distant metastasis (pM): Pathological assessment of distant metastases.
Residual tumour (pR)Residual tumour (pR): Pathological assessment of post-treatment residual tumour.
  • RX [Presence of residual tumour cannot be assessed. ]
  • RO [No residual tumour.]
  • R1 [Microscopic residual tumour.]
  • R2 [Macroscopic residual tumour.]
Histopathological grading (G)Histopathological grading (G): TNM histopathological grading classification.
  • GX [Grade of differentiation cannot be assessed.]
  • G1 [Well differentiated.]
  • G2 [Moderately differentiated.]
  • G3 [Poorly differentiated.]
  • G4 [Undifferentiated]
Pathological stagingPathological staging: The overall Pathological staging derived from each pT, pN and pM component. May include additional TNM descriptors.
Pathological stage groupingPathological stage grouping: The TNM Pathological stage grouping.
CommentComment: A text comment on the Pathological staging.
Other contributorsHeather Leslie Ocean Informatics Australia
Sam Heard Ocean Informatics Australia
Koray Atalag, University of Auckland, New Zealand
Translators